Allergenix is an Australian CRO with extensive expertise in sheep lung research and preclinical trials. Allergenix provides efficacy studies for the validation of new drug targets and drug delivery technologies. Sheep models include models for asthma, COPD, IPF, fibrosis, viral and bacterial lung infections, bronchitis, pneumonia and lung cancer.

In contrast to small rodents, sheep lungs exhibit a similar structure, lobation, tidal volume and alveoli diameter, and only a slightly higher breathing rate compared to the human lung. The relative size of sheep also allows for more clinically relevant testing of delivery technologies and dose alignment.

Allergenix provides in vitro, ex vivo and in vivo efficacy studies for preclinical validation of new drug targets and evaluation of emerging drug delivery technologies.
Our contract services include custom study design and data interpretation by experienced team of scientists.